Bipolar spectrum disorder masquerading as treatment resistant unipolar depression

By |2022-02-15T08:08:52-08:00February 15th, 2022|Brief Bulletins from the Field, We Know Psychiatry|

We are frequently consulted by patients with treatment resistant depression (TRD).Reference Fogelson and Leuchter1 Many of these patients have never met criteria for a manic episode so they are not diagnosed with bipolar disorder (BPD). Consequently, they have undergone trials of antidepressants with or without augmentation therapies without success.Reference Perlis, Uher [...]

Selective publication of antidepressant trials and its influence on apparent efficacy: A meta-analyses 

By |2022-02-04T09:52:31-08:00February 4th, 2022|Brief Bulletins from the Field, We Know Psychiatry|

Valid assessment of drug efficacy and safety requires an evidence base free of reporting bias. Using trial reports in Food and Drug Administration (FDA) drug approval packages as a gold standard,  researchers, Turner, Cipriani, Furukawa, et al. previously found that the published literature inflated the apparent efficacy of antidepressant drugs. [...]

Brain Inflammation Tied to Depression and Suicidal Thoughts

By |2021-11-11T17:05:01-08:00November 13th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

On individuals with major depressive disorder (MDD), particularly those who experience suicidal thinking, levels of translocator protein (TSPO), a marker of microglial inflammation, are increased, new research shows. Investigators from the University of Manchester, United Kingdom, found significantly higher levels of TSPO in patients with MDD than in healthy control [...]

OPINION: Recent Study Critical of Psychotropic Prescribing in the Elderly May Belie Real World Treatment

By |2021-11-11T17:14:40-08:00February 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

The number of retirement-age Americans taking at least three psychiatric drugs more than doubled between 2004 and 2013, even though almost half of them had no mental health diagnosis on record, according to a new study published in JAMA Internal Medicine and reported in today's New York Times. The new [...]

A Psychiatrist’s Quest to Understand PTSD: MDMA in the MIX

By |2021-11-11T17:15:19-08:00January 7th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

Charles Marmar, a 71-year-old psychiatrist in New York, has spent his career studying post traumatic stress disorder, which has symptoms such as sleep disruption and vivid flashbacks of the traumatic experience. PTSD is often associated with war: Between 11% and 20% of veterans who served in Iraq and Afghanistan have [...]

Title

Go to Top